Purchases and Sales Made in Q4 2021 in Cytokinetics Inc (CYTK)
This table provides information about the institutional ownership of Cytokinetics Inc (CYTK) during Q4 2021. The information is specifically focused on institutions that hold shares of CYTOKINETICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Sep 21, 2023
Q4 2021
|
Jefferies Group LLC
New York, NY |
SELL
|
- |
-62.5K- 86.21% |
$2.15M - $2.9M
|
10K
$491K
|
|
|
Feb 14, 2022
Q4 2021
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-71.6K- 78.37% |
$2.46M - $3.32M
|
19.8K
$971K
|
|
|
Jan 31, 2022
Q4 2021
|
Peregrine Capital Management LLC
|
SELL
|
- |
-72.1K- 25.0% |
$2.48M - $3.34M
|
216K
$10.6M
|
|
|
Feb 07, 2022
Q4 2021
|
Keybank National Association
|
SELL
|
- |
-75.7KClosed |
$2.6M - $3.51M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-88.3K- 66.66% |
$3.03M - $4.1M
|
44.2K
$2.17M
|
|
|
Feb 14, 2022
Q4 2021
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-89.8K- 13.24% |
$3.09M - $4.17M
|
589K
$28.9M
|
|
|
Feb 14, 2022
Q4 2021
|
Commodore Capital LP
New York, NY |
SELL
|
- |
-92K- 11.55% |
$3.16M - $4.27M
|
705K
$34.6M
|
|
|
Jan 19, 2022
Q4 2021
|
Frontier Capital Management CO LLC
|
SELL
|
- |
-94.6K- 12.53% |
$3.25M - $4.39M
|
661K
$32.4M
|
|
|
Feb 14, 2022
Q4 2021
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-124K- 12.27% |
$4.25M - $5.74M
|
885K
$43.5M
|
|
|
Feb 14, 2022
Q4 2021
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-262K- 89.12% |
$8.99M - $12.1M
|
31.9K
$1.57M
|
|
|
Feb 14, 2022
Q4 2021
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-272K- 53.37% |
$9.35M - $12.6M
|
238K
$11.7M
|
|
|
Feb 14, 2022
Q4 2021
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-300K- 30.0% |
$10.3M - $13.9M
|
700K
$34.4M
|
|
|
Feb 11, 2022
Q4 2021
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-300K- 23.08% |
$10.3M - $13.9M
|
1M
$49.1M
|
|
|
Feb 14, 2022
Q4 2021
|
Bain Capital Public Equity Management Ii, LLC
Boston, MA |
SELL
|
- |
-310K- 47.63% |
$10.7M - $14.4M
|
341K
$16.8M
|
|
|
Feb 10, 2022
Q4 2021
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-312K- 2.35% |
$10.7M - $14.5M
|
13M
$636M
|
|
|
Feb 14, 2022
Q4 2021
|
State Street Corp
Boston, MA |
SELL
|
- |
-325K- 7.54% |
$11.2M - $15.1M
|
3.99M
$196M
|
|
|
Feb 11, 2022
Q4 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-338KClosed |
$11.6M - $15.7M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Health Cor Management, L.P.
New York, NY |
SELL
|
- |
-340K- 78.34% |
$11.7M - $15.8M
|
94.1K
$4.62M
|
|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-426K- 43.25% |
$14.6M - $19.7M
|
559K
$27.4M
|
|
|
Feb 15, 2022
Q4 2021
|
Wasatch Advisors Inc
Salt Lake City, UT |
SELL
|
- |
-465K- 17.55% |
$16M - $21.6M
|
2.18M
$107M
|
|
|
Feb 14, 2022
Q4 2021
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-562K- 19.46% |
$19.3M - $26.1M
|
2.33M
$114M
|
|
|
Feb 14, 2022
Q4 2021
|
Farallon Capital Management LLC
San Francisco, CA |
SELL
|
- |
-562K- 20.58% |
$19.3M - $26.1M
|
2.17M
$107M
|
|
|
Feb 14, 2022
Q4 2021
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-695K- 21.99% |
$23.9M - $32.2M
|
2.47M
$121M
|
|
|
Feb 14, 2022
Q4 2021
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-728K- 47.36% |
$25M - $33.8M
|
809K
$39.7M
|